Fermer le menu

P. aeruginosa sepsis model bioluminescent strain BV1092

in vitro

  • Engineering and use of the same drug resistant clinical P. aeruginosa strain for in vitro and in vivo applications
  • Bacteria with stable genomic bioluminescence label
  • Well characterized P. aeruginosa isolate to enable drug candidate screening in different models

High throughput in vivo model

  • Galleria mellonella infection model
  • Bioluminescence used for real time analysis to better understand bacterial infections
  • Melanisation analysis to score larvae health
  • Allows fast and cost-efficient pre-screening of drug candidates
  • Model validation with Tobramycin

in vivo sepsis model

  • P. aeruginosa septicaemia model produced via tail-vein infections
  • Imaging allows the quantification and the dissemination visualization of bacteria
  • Model validation with tobramycin

For further informations, please contact us

    Civility
    		 Full name*
    		 Company
    Email*
    		 I'm interested in
    		 How did your hear about us
    Your message

    This site is protected by reCaptcha. Google's privacy policy and terms of use apply.

    Design by Supernova | Development by Wazimir